by Whitney
Posted on July 17, 2022
CIPO has been undergoing a strategic planning exercise and are happy to announce our new Strategic Plan 2022-2027. Our goals and objectives for the next three to five years will focus on sustainability, strong programming, community-building and advocacy. We also have a new mission, vision and values to better serve the immunodeficiency population in Canada. …
by Whitney
Posted on July 12, 2022
Three research studies are currently recruiting from members of the immunodeficiency community. Please see below for more details: Primary immunodeficiency patients who have been diagnosed with IgA sensitivity may be eligible to take part in a study being conducted by Ipsos on behalf of a pharmaceutical company. Please contact Julie Kanhnha 1-866-711-5948 for more information. Families with children…
by Whitney
Posted on July 12, 2022
AGM The Canadian Immunodeficiencies Patient Organization (CIPO) 2022 Annual General Meeting will take place virtually Saturday, October 1st at 4pm EST (1pm PST). All CIPO members are entitled to attend and vote at the AGM. Please register your intention to attend the AGM HERE. The AGM agenda will be circulated closer to the date. BOARD ELECTIONS – CALL FOR NOMINEES The Canadian Immunodeficiencies Patient Organization (CIPO)…
by Whitney
Posted on July 12, 2022
CIPO‘s Board of Directors and Governance Committee have reviewed and re-drafted the organizational bylaws given the input from our membership. The bylaws will be voted on at the AGM on October 1, 2022. Please send any comments or questions to info@cipo.ca Final Draft – CIPO By-laws 2021 (1)